The Washington Wizards announced that forward Cam Whitmore will miss the remainder of the season as he recovers from an ...

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under ...

Boston Scientific (NYSE:BSX) today announced a definitive agreement to acquire cardiovascular disease treatment device maker ...

Boston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a ...

Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots ...

Boston Scientific to acquire thrombectomy firm Penumbra for $14.5bn, expanding its cardiovascular portfolio as deal reshapes ...

Penumbra shares soared 12% to $351.46 on Thursday. Boston Scientific stock slumped 4.1%, making it one of the worst ...

Boston Scientific said on Thursday it will buy medtech firm Penumbra in a deal valued at about US$14.5 billion to expand its ...

In a bold move to expand its cardiovascular portfolio, Boston Scientific Corporation has announced its acquisition of Penumbra, Inc. This strategic partnership, valued at approximately $14.5 billion, ...

Boston Scientific Corp (NYSE:BSX) announced on Thursday that it has agreed to acquire medical technology company Penumbra ...